Full Text

Turn on search term navigation

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Jasminum sambac (L.) is a South Asian folkloric medicinal plant that has traditionally been used to treat cardiovascular problems. The current investigation was meticulously organized to explore the pharmacological foundation for the medicinal uses of J. sambac pertaining to cardiovascular ailments and to investigate the core mechanisms. Mechanistic investigation revealed that crude leaf extract of J. sambac produced ex-vivo vasorelaxant effects in endotheliumintact aorta ring preparation and hypotensive effect was recorded via pressure and force transducers coupled to the Power Lab Data Acquisition System. Moreover; J. sambac showed cardioprotective effects against adrenaline -induced left ventricular hypertrophy in rabbits observed hemodynamic. CK-MB, LDH, troponin, CRP, ALT, AST, ALP levels were shown to be lower in the myocardial infarction model, as were necrosis, oedema, and inflammatory cell recruitment in comparison to control. J. sambac has shown good antioxidant potential as well as prolonged the noradrenaline induced platelet adhesion. The vasorelaxant and cardioprotective effects in both in vivo and ex vivo experiments, which are enabled by activation of muscarinic receptor and/or releasing the nitric oxide and by reducing the adrenaline, induced oxidative stress, justifying its usage in cardiovascular disorders.

Details

Title
Jasminum sambac: A Potential Candidate for Drug Development to Cure Cardiovascular Ailments
Author
Imran Ahmad Khan 1 ; Hussain, Musaddique 1 ; Shaukat Hussain Munawar 2 ; Muhammad Omer Iqbal 3   VIAFID ORCID Logo  ; Shafia Arshad 4   VIAFID ORCID Logo  ; Ashira Manzoor 5 ; Mazhar Abbas Shah 5 ; Abbas, Khizar 5 ; Shakeel, Waleed 6 ; Syed, Shahzada Khurram 7   VIAFID ORCID Logo 

 Department of Pharmacology, The Islamia University of Bahawalpur, Bahwalpur 63100, Pakistan; [email protected] (M.H.); [email protected] (M.O.I.) 
 Department of Pharmacology and Toxicology, Cholistan University of Veterinary and Animal Sciences, Bahawalpur 63100, Pakistan; [email protected] 
 Department of Pharmacology, The Islamia University of Bahawalpur, Bahwalpur 63100, Pakistan; [email protected] (M.H.); [email protected] (M.O.I.); Key Laboratories of Marine Drugs (Ministry of Education), Shandong Laboratory of Glycoscience and Glycoengineering, School of Pharmacy, Ocean University of China, Qingdao 266100, China 
 Faculty of Medicine and Allied Health Sciences, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan; [email protected] 
 Fatima Tu Zahara Department of Life Sciences, Muhammad Institute of Medical and Allied Sciences, Multan 60000, Pakistan; [email protected] (A.M.); [email protected] (M.A.S.); [email protected] (K.A.) 
 Department of Pharmacology, Bahauddin Zakariya University, Multan 60000, Pakistan; [email protected] 
 Department of Basic Medical Sciences, School of Health Sciences, University of Management and Technology, Lahore 54770, Pakistan; [email protected] 
First page
5664
Publication year
2021
Publication date
2021
Publisher
MDPI AG
e-ISSN
14203049
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2576479108
Copyright
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.